Bristol Myers: presentations planned at ESC congress

(CercleFinance.com) - Bristol Myers Squibb has announced that it will be giving presentations on research into its cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, to be held from 30 August to 2 September in London.


According to the pharmaceutical group, these new analyses, including presentations on Camzyos (mavacamten), Eliquis (apixaban) and milvexian, reinforce its strength and expertise as a leader in cardiovascular disease.

We look forward to demonstrating how we are advancing the development of our drugs for the management of anticoagulation and thrombosis, as well as the treatment of obstructive HCM for patients in need, it adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.